U.S. Business Seeks Action, Not Trade War, In Xi (3)
Allergan offered its generics enterprise Actavis to Teva in August 2016 for $33 billion in money and a hundred million...
Allergan offered its generics enterprise Actavis to Teva in August 2016 for $33 billion in money and a hundred million...